6 results
8-K
EX-99.3
ZNTL
Zentalis Pharmaceuticals Inc
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
-77) 56.0 (34-75) 61.0 (34-83) Race and Ethnicity, N (%) White 24 (92.3) 34 (94.4) 16 (88.9) 34 (97.1) 108 (93.9) Black or African-American 0 0 0 0 0
8-K
EX-99.2
ZNTL
Zentalis Pharmaceuticals Inc
5 Jun 23
Regulation FD Disclosure
2:24pm
(93.9) Black or African- American 0 0 0 0 0 Asian 1 (3.8) 1 (2.8) 1 (5.6) 1 (2.9) 4 (3.5) Other / NR 1 (3.8) 1 (2.8) 1 (5.6) 0 3 (2.6) Hispanic (Yes
PRE 14A
ZNTL
Zentalis Pharmaceuticals Inc
18 Apr 23
Preliminary proxy
4:30pm
Background
African American or Black
Alaskan Native or American Indian
Asian
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
Two or More Races
- Prev
- 1
- Next